Genomics Identifies Medulloblastoma Subgroups That Are Enriched for Specific Genetic Alterations

Abstract

Genome-wide expression profiles can partition large tumor cohorts into subgroups that are enriched for specific genetic alterations. This approach may assist ultimately in the selection of patients for future clinical trials of molecular targeted therapies.